Advances in genetic profile and therapeutic strategy of pulmonary large cell neuroendocrine carcinoma

Advances in genetic profile and therapeutic strategy of pulmonary large cell neuroendocrine carcinoma

Pulmonary large cell neuroendocrine carcinoma (LCNEC) is a high-grade neuroendocrine carcinoma (HGNEC) accounting for 3% of primary lung cancer, and characterized by strong invasion, high heterogeneity, and extremely poor prognosis. At present, the diagnosis and treatment of LCNEC remains controvers...

Full description

Bibliographic Details
Main Authors: Siyu Zhu, Xinyue Wang, Hui Li, Peiyan Zhao, Jingjing Liu, Liang Zhang, Ying Cheng
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-02-01
Series:Frontiers in Medicine
Subjects:
pulmonary large cell neuroendocrine carcinoma
molecular subtype
biomarkers
therapeutic advances
immunotherapy
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2024.1326426/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2024.1326426/full

Similar Items